Holdings (Monthly)
Guide ↗
Select Health Care Portfolio
· Fidelity Select Portfolios| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | ELI LILLY and CO | 532457108 | Feb 2026 | 420,000 | +12,000 | $464.1M | +8.1% | 8.03% | EC |
| 2 | DANAHER CORP | 235851102 | Feb 2026 | 2,180,000 | +300,000 | $398.2M | +0.6% | 6.89% | EC |
| 3 | JOHNSON and JOHNSON | 478160104 | Feb 2026 | 1,260,000 | -140,000 | $283.9M | -18.4% | 4.91% | EC |
| 4 | THERMO FISHER SCIENTIFIC INC | 883556102 | Feb 2026 | 508,000 | +296,000 | $250.2M | +126.5% | 4.33% | EC |
| 5 | UNITEDHEALTH GROUP INC | 91324P102 | Feb 2026 | 530,000 | +250,000 | $201.6M | +145.5% | 3.49% | EC |
| 6 | ALNYLAM PHARMACEUTICALS INC | 02043Q107 | Feb 2026 | 460,000 | +120,000 | $138.9M | +22.7% | 2.40% | EC |
| 7 | GILEAD SCIENCES INC | 375558103 | Feb 2026 | 950,000 | -130,000 | $127.7M | -20.6% | 2.21% | EC |
| 8 | BOSTON SCIENTIFIC CORP | 101137107 | Feb 2026 | 2,600,000 | -2,250,000 | $125.6M | -66.3% | 2.17% | EC |
| 9 | ASCENDIS PHARMA A/S | N/A | Feb 2026 | 560,000 | +111,414 | $125.5M | +1963.2% | 2.17% | EC |
| 10 | Fidelity Revere Street Trust | 31635A303 | Feb 2026 | 125,434,819 | -99,096,328 | $125.4M | -44.1% | 2.17% | STIV |
| 11 | ABBVIE INC | 00287Y109 | Feb 2026 | 540,000 | -600,000 | $117.6M | -55.6% | 2.03% | EC |
| 12 | UCB SA | N/A | Feb 2026 | 400,000 | NEW | $117.4M | — | 2.03% | EC |
| 13 | BIO TECHNE CORP | 09073M104 | Feb 2026 | 1,900,000 | +1,800,000 | $98.2M | +1564.3% | 1.70% | EC |
| 14 | MERCK and CO INC | 58933Y105 | Feb 2026 | 780,000 | -500,000 | $92.6M | -41.6% | 1.60% | EC |
| 15 | ARGENX SE | 04016X101 | Feb 2026 | 108,000 | -92,000 | $90.3M | -41.1% | 1.56% | EC |
| 16 | CVS HEALTH CORP | 126650100 | Feb 2026 | 820,000 | -680,000 | $74.6M | -37.8% | 1.29% | EC |
| 17 | NUVALENT INC | 670703107 | Feb 2026 | 670,000 | -90,000 | $74.0M | -4.5% | 1.28% | EC |
| 18 | NATERA INC | 632307104 | May 2026 | 328,000 | NEW | $73.3M | — | 1.27% | EC |
| 19 | BRIGHTSPRING HEALTH SERVICES INC | 10950A106 | Feb 2026 | 1,150,000 | -930,000 | $70.9M | -17.7% | 1.23% | EC |
| 20 | VIATRIS INC | 92556V106 | May 2026 | 4,280,000 | NEW | $69.6M | — | 1.20% | EC |
| 21 | MODERNA INC | 60770K107 | Feb 2026 | 1,450,000 | -150,000 | $68.4M | -20.2% | 1.18% | EC |
| 22 | CENCORA INC | 03073E105 | Feb 2026 | 245,000 | +45,000 | $66.0M | -11.3% | 1.14% | EC |
| 23 | WEST PHARMACEUTICAL SVCS INC | 955306105 | May 2026 | 200,000 | NEW | $64.6M | — | 1.12% | EC |
| 24 | AGILENT TECHNOLOGIES INC | 00846U101 | May 2026 | 470,800 | NEW | $63.8M | — | 1.10% | EC |
| 25 | EDWARDS LIFESCIENCES CORP | 28176E108 | Feb 2026 | 728,000 | -872,000 | $63.0M | -54.5% | 1.09% | EC |
| 26 | XENON PHARMACEUTICALS INC | 98420N105 | Feb 2026 | 1,150,000 | -140,000 | $62.9M | +12.9% | 1.09% | EC |
| 27 | CARIS LIFE SCIENCES INC | 142152107 | Feb 2026 | 3,750,000 | +700,000 | $62.7M | +2.1% | 1.08% | EC |
| 28 | ROYALTY PHARMA PLC | N/A | Feb 2026 | 1,120,000 | NEW | $62.5M | — | 1.08% | EC |
| 29 | COGENT BIOSCIENCES INC | 19240Q201 | Feb 2026 | 1,750,000 | -810,000 | $61.2M | -38.5% | 1.06% | EC |
| 30 | GUARDANT HEALTH INC | 40131M109 | Feb 2026 | 460,000 | +266,000 | $59.7M | +227.5% | 1.03% | EC |
| 31 | VAXCYTE INC | 92243G108 | Feb 2026 | 1,160,000 | +160,000 | $59.6M | -3.4% | 1.03% | EC |
| 32 | VERACYTE INC | 92337F107 | Feb 2026 | 1,280,000 | +249,856 | $59.3M | +57.4% | 1.03% | EC |
| 33 | REPLIGEN CORP | 759916109 | Feb 2026 | 460,000 | +32,000 | $57.0M | +3.5% | 0.99% | EC |
| 34 | SPYRE THERAPEUTICS INC | 00773J202 | Feb 2026 | 760,000 | -180,000 | $55.9M | +38.2% | 0.97% | EC |
| 35 | JAZZ PHARMACEUTICALS PLC | N/A | Feb 2026 | 235,000 | NEW | $55.6M | — | 0.96% | EC |
| 36 | REVOLUTION MEDICINES INC | 76155X100 | Feb 2026 | 350,000 | +250,000 | $55.1M | +440.3% | 0.95% | EC |
| 37 | LEGEND BIOTECH CORP | 52490G102 | Feb 2026 | 2,000,000 | -800,000 | $54.3M | +2.1% | 0.94% | EC |
| 38 | ROCHE HOLDING AG | N/A | Feb 2026 | 128,000 | NEW | $54.0M | — | 0.93% | EC |
| 39 | PRIVIA HEALTH GROUP INC | 74276R102 | Feb 2026 | 2,500,000 | +220,000 | $53.8M | -0.7% | 0.93% | EC |
| 40 | INSMED INC | 457669307 | Feb 2026 | 500,000 | -60,000 | $53.5M | -36.1% | 0.92% | EC |
| 41 | BRUKER CORP | 116794108 | May 2026 | 850,000 | NEW | $50.1M | — | 0.87% | EC |
| 42 | ORUKA THERAPEUTICS INC | 687604108 | Feb 2026 | 833,100 | -173,410 | $48.8M | +40.8% | 0.84% | EC |
| 43 | 10X GENOMICS INC | 88025U109 | Feb 2026 | 1,600,000 | — | $45.3M | +22.8% | 0.78% | EC |
| 44 | AXSOME THERAPEUTICS INC | 05464T104 | Feb 2026 | 190,000 | +72,000 | $44.6M | +130.4% | 0.77% | EC |
| 45 | ENLIVEN THERAPEUTICS INC | 29337E102 | Feb 2026 | 1,120,000 | -160,000 | $44.3M | +16.6% | 0.77% | EC |
| 46 | ELEVANCE HEALTH INC | 036752103 | May 2026 | 110,000 | NEW | $43.3M | — | 0.75% | EC |
| 47 | CRINETICS PHARMACEUTICALS INC | 22663K107 | Feb 2026 | 1,200,000 | -80,000 | $42.7M | -18.9% | 0.74% | EC |
| 48 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | N/A | Feb 2026 | 844,907 | NEW | $40.9M | — | 0.71% | EC |
| 49 | ALIGNMENT HEALTHCARE INC | 01625V104 | Feb 2026 | 2,600,000 | +600,000 | $39.8M | +3.6% | 0.69% | EC |
| 50 | LIFESTANCE HEALTH GROUP INC | 53228F101 | Feb 2026 | 4,979,400 | +479,400 | $38.4M | +17.8% | 0.66% | EC |
| 51 | ROIVANT SCIENCES LTD | N/A | Feb 2026 | 1,280,000 | NEW | $38.4M | — | 0.66% | EC |
| 52 | MINERALYS THERAPEUTICS INC | 603170101 | Feb 2026 | 1,180,000 | +180,000 | $37.2M | +27.0% | 0.64% | EC |
| 53 | KYMERA THERAPEUTICS INC | 501575104 | Feb 2026 | 450,000 | +206,414 | $36.6M | +64.7% | 0.63% | EC |
| 54 | MEDLINE INC | 58507V107 | Feb 2026 | 1,000,000 | — | $36.6M | -23.0% | 0.63% | EC |
| 55 | PRAXIS PRECISION MEDICINES INC. | 74006W207 | Feb 2026 | 100,000 | -60,000 | $35.0M | -35.0% | 0.61% | EC |
| 56 | INTUITIVE SURGICAL INC | 46120E602 | Feb 2026 | 75,000 | -25,000 | $31.8M | -36.7% | 0.55% | EC |
| 57 | DISC MEDICINE INC | 254604101 | Feb 2026 | 450,000 | -200,000 | $31.3M | -27.7% | 0.54% | EC |
| 58 | CG ONCOLOGY INC | 156944100 | Feb 2026 | 500,000 | -300,000 | $31.1M | -33.8% | 0.54% | EC |
| 59 | HEARTFLOW INC | 42238D107 | Feb 2026 | 1,000,000 | +50,000 | $31.0M | +40.8% | 0.54% | EC |
| 60 | BIOGEN INC | 09062X103 | Feb 2026 | 150,000 | +100,000 | $29.4M | +206.5% | 0.51% | EC |
| 61 | TRAVERE THERAPEUTICS INC | 89422G107 | Feb 2026 | 570,000 | +20,000 | $26.9M | +64.1% | 0.47% | EC |
| 62 | SARTORIUS STEDIM BIOTECH | N/A | Feb 2026 | 128,000 | NEW | $26.6M | — | 0.46% | EC |
| 63 | VIRIDIAN THERAPEUTICS INC | 92790C104 | Feb 2026 | 1,500,000 | -1,319,500 | $26.4M | -68.1% | 0.46% | EC |
| 64 | BEONE MEDICINES LTD | 07725L102 | Feb 2026 | 90,000 | — | $25.9M | -9.2% | 0.45% | EC |
| 65 | PHARVARIS BV | N/A | Feb 2026 | 800,000 | NEW | $24.1M | — | 0.42% | EC |
| 66 | RELAY THERAPEUTICS INC | 75943R102 | May 2026 | 1,680,000 | NEW | $23.6M | — | 0.41% | EC |
| 67 | NEWAMSTERDAM PHARMA COMPANY NV | N/A | Feb 2026 | 690,000 | NEW | $23.2M | — | 0.40% | EC |
| 68 | MIRUM PHARMACEUTICALS INC | 604749101 | Feb 2026 | 220,000 | +92,000 | $22.3M | +89.0% | 0.39% | EC |
| 69 | WAYSTAR HOLDING CORP | 946784105 | Feb 2026 | 1,080,000 | -1,420,000 | $21.5M | -66.5% | 0.37% | EC |
| 70 | STRUCTURE THERAPEUTICS INC | 86366E106 | Feb 2026 | 540,000 | -80,000 | $21.2M | -45.6% | 0.37% | EC |
| 71 | SCHOLAR ROCK HOLDING CORP | 80706P103 | Feb 2026 | 430,000 | +313,485 | $21.2M | +311.0% | 0.37% | EC |
| 72 | IRHYTHM TECHNOLOGIES INC | 450056106 | May 2026 | 180,000 | NEW | $20.5M | — | 0.35% | EC |
| 73 | AMYLYX PHARMACEUTICALS INC | 03237H101 | Feb 2026 | 1,420,000 | — | $20.4M | -5.4% | 0.35% | EC |
| 74 | ZENAS BIOPHARMA INC | 98937L105 | Feb 2026 | 1,080,000 | — | $19.9M | -30.2% | 0.34% | EC |
| 75 | OLEMA PHARMACEUTICALS INC | 68062P106 | Feb 2026 | 1,500,000 | +150,000 | $19.8M | -39.4% | 0.34% | EC |
| 76 | STOKE THERAPEUTICS INC | 86150R107 | Feb 2026 | 628,000 | -122,000 | $19.4M | -28.9% | 0.34% | EC |
| 77 | DIANTHUS THERAPEUTICS INC | 252828108 | May 2026 | 207,448 | NEW | $19.3M | — | 0.33% | EC |
| 78 | KESTRA MEDICAL TECHNOLOGIES INC | N/A | Feb 2026 | 900,000 | NEW | $19.1M | — | 0.33% | EC |
| 79 | MBX BIOSCIENCES INC | 55287L101 | Feb 2026 | 600,000 | +320,000 | $18.9M | +107.2% | 0.33% | EC |
| 80 | VERADERMICS INC | 922967104 | May 2026 | 180,000 | NEW | $18.2M | — | 0.31% | EC |
| 81 | CYTOMX THERAPEUTICS INC | 23284F105 | Feb 2026 | 5,000,000 | +1,600,000 | $18.0M | -1.4% | 0.31% | EC |
| 82 | VIKING THERAPEUTICS INC | 92686J106 | Feb 2026 | 540,000 | -60,000 | $17.7M | -12.9% | 0.31% | EC |
| 83 | CLEERLY INC | N/A | Feb 2026 | 1,285,367 | NEW | $15.5M | — | 0.27% | EP |
| 84 | INSULET CORP | 45784P101 | Feb 2026 | 100,000 | -170,000 | $14.5M | -78.2% | 0.25% | EC |
| 85 | IMMUNOCORE HOLDINGS PLC | 45258D105 | Feb 2026 | 500,000 | — | $14.4M | -10.6% | 0.25% | EC |
| 86 | 10X GENOMICS INC | N/A | Feb 2026 | 500,000 | NEW | $14.2M | — | 0.24% | EC |
| 87 | TREVI THERAPEUTICS INC | 89532M101 | Feb 2026 | 1,000,000 | — | $14.1M | +18.6% | 0.24% | EC |
| 88 | SUMMIT THERAPEUTICS INC | 86627T108 | Feb 2026 | 800,000 | -200,000 | $14.0M | -15.4% | 0.24% | EC |
| 89 | JADE BIOSCIENCES INC | 008064206 | Feb 2026 | 640,000 | +240,000 | $13.5M | +127.0% | 0.23% | EC |
| 90 | DAMORA THERAPEUTICS INC | 36322Q206 | Feb 2026 | 500,000 | — | $12.4M | -15.9% | 0.22% | EC |
| 91 | GMR SOLUTIONS INC | 38013D106 | May 2026 | 993,539 | NEW | $12.4M | — | 0.21% | EC |
| 92 | CANDID THERAPEUTICS | N/A | Feb 2026 | 3,162,302 | NEW | $11.7M | — | 0.20% | EP |
| 93 | Fidelity Revere Street Trust | 31635A105 | Feb 2026 | 10,759,186 | -12,565,726 | $10.8M | -53.9% | 0.19% | STIV |
| 94 | EDGEWISE THERAPEUTICS INC | 28036F105 | May 2026 | 294,000 | NEW | $10.0M | — | 0.17% | EC |
| 95 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 316,310 | NEW | $9.7M | — | 0.17% | EP |
| 96 | TYRA BIOSCIENCES INC | 90240B106 | May 2026 | 280,000 | NEW | $9.4M | — | 0.16% | EC |
| 97 | ENDEAVOR BIOMEDICINES INC | N/A | Feb 2026 | 1,366,212 | NEW | $8.9M | — | 0.15% | EP |
| 98 | KARDIUM INC/US | N/A | Feb 2026 | 15,888,877 | NEW | $8.3M | — | 0.14% | EP |
| 99 | INSIGHTEC LTD | N/A | Feb 2026 | 11,853,768 | NEW | $8.2M | — | 0.14% | EP |
| 100 | SHOULDER INNOVATIONS INC | 82537J108 | Feb 2026 | 545,286 | +448,586 | $8.0M | +511.3% | 0.14% | EC |
| 101 | OUTSET MEDICAL INC | 690145206 | Feb 2026 | 1,520,000 | — | $7.4M | +40.1% | 0.13% | EC |
| 102 | APOGEE THERAPEUTICS INC | 03770N101 | Feb 2026 | 90,007 | +10,316 | $7.4M | +32.5% | 0.13% | EC |
| 103 | UPSTREAM BIO INC | 91678A107 | Feb 2026 | 800,000 | — | $6.7M | +8.9% | 0.12% | EC |
| 104 | ALUMIS INC | 022307102 | May 2026 | 301,364 | NEW | $6.5M | — | 0.11% | EC |
| 105 | ANNEXON INC | 03589W102 | Feb 2026 | 1,200,000 | — | $6.5M | -3.2% | 0.11% | EC |
| 106 | ALEDADE INC | N/A | Feb 2026 | 201,220 | NEW | $6.5M | — | 0.11% | EP |
| 107 | FIRST TRACKS BIOTHERAPEUTICS INC | 337185102 | May 2026 | 400,000 | NEW | $6.4M | — | 0.11% | EC |
| 108 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 572,265 | NEW | $6.3M | — | 0.11% | EP |
| 109 | ALMAR BIOSCIENCES INC | 010911105 | May 2026 | 300,000 | NEW | $6.1M | — | 0.11% | EC |
| 110 | CONTINEUM THERAPEUTICS INC | 21217B100 | Feb 2026 | 450,000 | — | $6.1M | -12.1% | 0.10% | EC |
| 111 | PARABILIS MEDICINES INC | N/A | Feb 2026 | 869,000 | NEW | $6.0M | — | 0.10% | EP |
| 112 | CELLCENTRIC LTD | N/A | Feb 2026 | 1,214,928 | NEW | $5.8M | — | 0.10% | EP |
| 113 | OCULAR THERAPEUTIX INC | 67576A100 | Feb 2026 | 494,535 | — | $4.5M | +0.8% | 0.08% | EC |
| 114 | KARDIUM INC/US | N/A | Feb 2026 | 4,095,710 | NEW | $4.4M | — | 0.08% | DBT |
| 115 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 8,252,708 | NEW | $3.9M | — | 0.07% | EP |
| 116 | MANUS BIO INC | N/A | Feb 2026 | 1,079,396 | NEW | $3.6M | — | 0.06% | EP |
| 117 | PERCEPTIVE CAPITAL SOLUTIONS CORP | N/A | Feb 2026 | 320,567 | NEW | $3.2M | — | 0.06% | EC |
| 118 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | NEW | $3.1M | — | 0.05% | EP |
| 119 | ELEMENT BIOSCIENCES INC | N/A | Feb 2026 | 413,355 | NEW | $3.1M | — | 0.05% | EP |
| 120 | ZENAS BIOPHARMA INC | N/A | Feb 2026 | 160,865 | NEW | $3.0M | — | 0.05% | EC |
| 121 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 3,696,429 | NEW | $2.8M | — | 0.05% | EP |
| 122 | ASIMOV INC | N/A | Feb 2026 | 101,438 | NEW | $2.5M | — | 0.04% | EP |
| 123 | WUGEN INC | N/A | Feb 2026 | 2,299,153 | NEW | $2.4M | — | 0.04% | DBT |
| 124 | HEAL THRIVE HOLDINGS LLC | N/A | Feb 2026 | 473,270 | NEW | $2.3M | — | 0.04% | EC |
| 125 | DMED BIOPHARMACEUTICAL CO LTD | N/A | Feb 2026 | 330,316 | NEW | $2.3M | — | 0.04% | EP |
| 126 | HEMAB THERAPEUTICS HOLDINGS INC | 423494103 | May 2026 | 65,000 | NEW | $1.9M | — | 0.03% | EC |
| 127 | ALEDADE INC | N/A | Feb 2026 | 56,664 | NEW | $1.8M | — | 0.03% | EP |
| 128 | KARDIUM INC/US | N/A | Feb 2026 | 3,477,566 | NEW | $1.8M | — | 0.03% | EP |
| 129 | IMMUNOME INC | 45257U108 | Feb 2026 | 64,792 | +17,966 | $1.4M | +38.2% | 0.02% | EC |
| 130 | GALVANIZE THERAPEUTICS | N/A | Feb 2026 | 1,035,085 | NEW | $1.4M | — | 0.02% | DBT |
| 131 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $1.3M | — | 0.02% | EC |
| 132 | SALUDA MEDICAL INC | N/A | Feb 2026 | 338,168 | NEW | $875K | — | 0.02% | EC |
| 133 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $865K | — | 0.01% | EC |
| 134 | WUGEN INC | N/A | Feb 2026 | 454,342 | NEW | $704K | — | 0.01% | EP |
| 135 | CYCLERION THERAPEUTICS INC | N/A | Feb 2026 | 275,300 | NEW | $702K | — | 0.01% | EC |
| 136 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $685K | — | 0.01% | EC |
| 137 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $588K | — | 0.01% | EC |
| 138 | INMED PHARMACEUTICALS INC | N/A | Feb 2026 | 206,100 | NEW | $476K | — | 0.01% | EC |
| 139 | ELEVATEBIO, LLC | N/A | Feb 2026 | 254,900 | NEW | $469K | — | 0.01% | EP |
| 140 | SALUDA MEDICAL INC | N/A | Feb 2026 | 1,600,000 | NEW | $414K | — | 0.01% | EC |
| 141 | KARDIUM INC/US | N/A | Feb 2026 | 723,517 | NEW | $376K | — | 0.01% | EP |
| 142 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $361K | — | 0.01% | EC |
| 143 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $352K | — | 0.01% | EC |
| 144 | MEDICAL MICROINSTRUMENTS INC | N/A | Feb 2026 | 15,815 | NEW | $173K | — | 0.00% | EC |
| 145 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $115K | — | 0.00% | EC |
| 146 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $57K | — | 0.00% | EC |
| 147 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $57K | — | 0.00% | EC |
| 148 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $43K | — | 0.00% | EC |
| 149 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $27K | — | 0.00% | EC |
| 150 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $26K | — | 0.00% | EC |
| 151 | CYCLERION THERAPEUTICS INC | 23255M204 | May 2026 | 3,000 | NEW | $9K | — | 0.00% | EC |
| 152 | TUBULIS GMBH | N/A | Feb 2026 | 12,300 | NEW | $246 | — | 0.00% | EC |
| ✕ | ASCENDIS PHARMA A/S | 04351P101 | — | 716,000 | SOLD | $167.2M | — | — | — |
| ✕ | MCKESSON CORP | 58155Q103 | — | 95,000 | SOLD | $93.8M | — | — | — |
| ✕ | STRYKER CORP | 863667101 | — | 150,000 | SOLD | $58.1M | — | — | — |
| ✕ | VEEVA SYS INC | 922475108 | — | 300,000 | SOLD | $54.6M | — | — | — |
| ✕ | CENTESSA PHARMACEUTICALS PLC | 152309100 | — | 1,650,000 | SOLD | $44.3M | — | — | — |
| ✕ | CYTOKINETICS INC | 23282W605 | — | 600,000 | SOLD | $37.3M | — | — | — |
| ✕ | BIONTECH SE | 09075V102 | — | 280,000 | SOLD | $30.9M | — | — | — |
| ✕ | CIGNA GROUP (THE) | 125523100 | — | 100,000 | SOLD | $29.0M | — | — | — |
| ✕ | SOLENO THERAPEUTICS INC | 834203309 | — | 400,000 | SOLD | $15.6M | — | — | — |
| ✕ | IQVIA HOLDINGS INC | 46266C105 | — | 60,000 | SOLD | $10.7M | — | — | — |
| ✕ | OMADA HEALTH INC | 68170A108 | — | 850,000 | SOLD | $10.4M | — | — | — |
| ✕ | RAPPORT THERAPEUTICS INC | 75383L102 | — | 285,000 | SOLD | $8.3M | — | — | — |
| ✕ | ACUMEN PHARMACEUTICALS INC | 00509G209 | — | 1,140,000 | SOLD | $3.6M | — | — | — |
| ✕ | SURGERY PARTNERS INC | 86881A100 | — | 145,113 | SOLD | $2.2M | — | — | — |